Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Effect of Adenotonsillectomy on Spinal Curve Magnitude in Children With Sleep-Disordered Breathing

Key facts

Where
Wenzhou, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 15 years old?

Source: NCT07332780, who can take part

Where in China

  • The Second Affiliated Hospital of Wenzhou Medical UniversityWenzhou, ChinaContact: Xiangyang Wang, MDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Second Affiliated Hospital of Wenzhou Medical University
Trial code
NCT07332780
Record updated
15 May 2026
Original description
This study aims to determine the effect of adenotonsillectomy (AT) surgery on the progression of spinal curvature in children with mild sleep-disordered breathing (SDB) and concurrent scoliosis, as well as its potential role in preventing the de novo development of scoliosis in children with SDB.Read full original descriptionShow less

A Randomized Controlled Study of Adenotonsillectomy on Spinal Curve Magnitude in Children With Mild Sleep-Disordered Breathing

This study aims to determine the effect of adenotonsillectomy (AT) surgery on the progression of spinal curvature in children with mild sleep-disordered breathing (SDB) and concurrent scoliosis, as well as its potential role in preventing the de novo development of scoliosis in children with SDB.

Inclusion: Age between 6 and 15 years; Diagnosed with mild SDB, defined as: Obstructive Apnea-Hypopnea Index (OAHI) ≤5 events/hour on a laboratory-based PSG performed within the past 6 months, AND parental report of habitual obstructive breathing symptoms (e.g., snoring, mouth-breathing, witnessed apneas) occurring >3 nights per week on average; Tonsillar hypertrophy grade ≥2 (on a scale of 0-4) and deemed an appropriate candidate for AT upon ENT evaluation (i.e., no absolute contraindications such as submucous cleft palate); Has undergone radiographic screening for idiopathic scoliosis at the first clinic visit; Skeletally immature (Risser sign 0-3) with spinal Cobb angle < 40 degrees; Informed consent/assent provided by the participant and guardian.

Exclusion: Previous tonsillectomy or adenoidectomy; Severe OSA (OAHI >10 or as per clinician judgment) or significant hypoxemia requiring immediate CPAP therapy; Severe chronic conditions that could confound outcomes, including but not limited to:; Known syndromic, neuromuscular, or congenital musculoskeletal causes of scoliosis; History of spine surgery or significant spinal injury; Spinal tumor; Leg length discrepancy >20 mm; Severe cardiopulmonary disease (e.g., cystic fibrosis, congenital heart disease); Significant cardiac arrhythmia noted on PSG; Bleeding disorders, Sickle Cell Disease; Uncontrolled diabetes, narcolepsy, or asthma; Known genetic, craniofacial, neurological, or psychiatric conditions likely to affect the airway or study participation; Severe obesity (BMI z-score ≥ 3); Unwillingness or inability to comply with study procedures; Plans to relocate outside the study area within 24 months; Recurrent tonsillitis meeting guideline criteria for immediate AT.

ClinicalTrials.gov NCT07332780